Demetriades & Papaellinas Ltd, Novartis Farma - Pharmaceutical Products, S.A., Novartis Farma S.p.A., Novartis Farma S.p.A., Novartis Farmacéutica, S.A., Novartis Finland Oy, Novartis Healthcare A/S, Novartis (Hellas) S.A.C.I., Novartis Hungaria Kft., Novartis Pharma B.V., Novartis Pharma GmbH, Novartis Pharma GmbH, Novartis Pharma GmbH, Novartis Pharma nv/sa, Novartis Pharma S.A.S., Novartis Poland Sp. z o.o., Novartis Sverige AG

The medicine is used in patients after an organ, bone marrow, or stem cell transplant to prevent transplant rejection. It is also used in the treatment of autoimmune diseases, such as certain eye diseases, severe skin diseases (atopic dermatitis, psoriasis), rheumatoid arthritis, and nephrotic syndrome.

Dosage form: solution, oral

ATC: L04AD01